Kayentis, SAS is a global provider of eCOA (electronic Clinical Outcome Assessment) and Decentralized Clinical Trial solutions (DCTs) that simplifies and enhances the collection of clinical trial data for patients and sites. Since its establishment in 2004, Kayentis has specialized in eCOA solutions for phases II/III across various therapeutic areas. With over 280 clinical trials conducted in 85 countries, the company has developed a comprehensive range of services to support decentralized and hybrid trials. Kayentis' technology enables electronic data capture for patients, offering adaptable tools that cater to all clinical study needs. With offices in the US, France, and Japan, the company employs 185 staff and has a strong track record of providing digital data collection services in multiple languages.